Device Trial Radar · NCT06062329
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
110
Actual
Start
Dec 13, 2023
Primary completion
May 4, 2025
Study completion May 29, 2025
Sponsor
- Lead sponsor
- Imperative Care, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 2, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
Conditions
- Acute Pulmonary Embolism
- Thromboembolism
- Emboli, Pulmonary
- Thrombosis
- Thrombus; Embolism
- Embolism
- Cardiovascular Diseases
- Vascular Diseases
Interventions
Symphony Thrombectomy SystemDevice
The Symphony Thrombectomy System will be used to restore blood flow to the pulmonary arteries by removing thrombus/embolus/clot using aspiration and mechanical clot engagement.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Major Adverse EventsTime frame: 48 hours
- Mean Reduction of RV/LV RatioTime frame: Baseline to 48 hours
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Huntsville Hospital
Huntsville, Alabama
Cedars-Sinai Medical Center
Los Angeles, California
First Coast Cardiovascular Institute
Jacksonville, Florida
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.